Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
Pfizer
Pfizer
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
Cancer Research UK
National Cancer Institute (NCI)
Cancer Research UK
Ikena Oncology
Eli Lilly and Company
National Cancer Institute (NCI)
Aminex Therapeutics, Inc.
Novartis
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
University College, London
GE Healthcare
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center